Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Hershey | HSY | Nov 25, 2024 | 175.54 | +0.42 |
The Herzfeld Caribbean Basin Fund | CUBA | Nov 25, 2024 | 2.42 | -0.42 |
The Honest Company | HNST | Nov 25, 2024 | 8.57 | +5.15 |
The Intergroup | INTG | Nov 25, 2024 | 13.84 | +0.22 |
The J.M Smucker Company | SJM | Nov 25, 2024 | 113.62 | +0.28 |
The Joint | JYNT | Nov 25, 2024 | 11.95 | +1.70 |
The Marygold Companies | MGLD | Nov 25, 2024 | 1.49 | +0.68 |
The ODP | ODP | Nov 25, 2024 | 26.94 | -1.17 |
The OLB Group | OLB | Nov 25, 2024 | 1.85 | -5.13 |
The Oncology Institute | TOI | Nov 25, 2024 | 0.15 | -1.62 |
The ONE Group Hospitality | STKS | Nov 25, 2024 | 3.53 | +2.92 |
The Pennant Group | PNTG | Nov 25, 2024 | 30.56 | -1.86 |
The Real Brokerage | REAX | Nov 25, 2024 | 5.49 | +2.81 |
The Real Estate Select Sector SPDR Fund | XLRE | Nov 25, 2024 | 44.68 | +1.34 |
The RealReal | REAL | Nov 25, 2024 | 5.33 | +12.45 |
The RMR Group A | RMR | Nov 25, 2024 | 22.20 | +0.86 |
The Shyft Group | SHYF | Nov 25, 2024 | 14.35 | +4.14 |
The Trade Desk A | TTD | Nov 25, 2024 | 129.35 | -0.27 |
The9 ADR | NCTY | Nov 25, 2024 | 11.10 | +0.36 |
TherapeuticsMD | TXMD | Nov 25, 2024 | 1.39 | +1.46 |
Theratechnologies | THTX | Nov 25, 2024 | 1.20 | 0.00 |
Theravance Biopharma | TBPH | Nov 25, 2024 | 9.47 | 0.00 |
Theriva Biologics | TOVX | Nov 25, 2024 | 1.30 | +1.56 |
Thermo Fisher Scientific | TMO | Nov 25, 2024 | 514.20 | +0.18 |
Thermon Group | THR | Nov 25, 2024 | 32.24 | +0.84 |
Third Coast Bancshares | TCBX | Nov 25, 2024 | 36.21 | +0.25 |
Third Harmonic | THRD | Nov 25, 2024 | 12.44 | -0.24 |
Thomson Reuters | TRI | Nov 25, 2024 | 160.72 | -0.30 |
Thor Industries | THO | Nov 25, 2024 | 115.54 | +3.00 |
Thornburg Income Builder Opportunities Fund | TBLD | Nov 25, 2024 | 16.64 | +0.64 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.